Latest news
Supernus And Indivior To Merge And Create $2.2 Billion CNS Biopharmaceutical Company - Pulse 2.0Pulse 2.0 · Wed, 05 Aug 2026 16:41:40 GMTSupernus and Indivior to Merge, Creating Diversified CNS Biopharma Company - Contract PharmaContract Pharma · Tue, 04 Aug 2026 17:08:33 GMT$1.8bn merger unites Supernus and Indivior in CNS therapeutics play - BioXconomyBioXconomy · Tue, 04 Aug 2026 16:38:23 GMTINDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 16:18:00 GMTSupernus and Indivior merge to create scaled, CNS-focused entity - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 11:57:39 GMTRaleigh drug factory part of $2B merger - The Business JournalsThe Business Journals · Tue, 04 Aug 2026 10:30:00 GMTSupernus, Indivior Launch Communications on Proposed Merger - TipRanksTipRanks · Tue, 04 Aug 2026 04:00:52 GMTIndivior and Supernus (SUPN) outline tax-free all-stock CNS merger of equals - Stock TitanStock Titan · Mon, 03 Aug 2026 23:15:00 GMT